Spots Global Cancer Trial Database for Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
Official Title: Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
Study ID: NCT03590275
Conditions
Interventions
Study Description
Brief Summary: The aim of this study is to identify new prognostic factors in patients affected by advanced pancreatic carcinoma treated with first line chemotherapy with FOLFIRINOX regimen. Primary objective is the identification of clinical, laboratory and pathologic factors affecting overall survival of these patients.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Oncologia ASL BI, Ponderano, Biella, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì Cesena, Italy
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia FPO - IRCSS, Candiolo, Torino, Italy
ASL VCO, Ospedale Castelli Verbania, Verbania, Torino, Italy
A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica, Pisa, , Italy
P.O. Molinette Oncologia 1, Torino, , Italy
A.O. Ordine Mauriziano, Torino, , Italy
Contact Details
Name: Lorenzo Fornaro, MD
Affiliation: Azienda Ospedaliero, Universitaria Pisana
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
